| Cigna EviCore | MOL.AD.304.A: Medical Necessity Review Information Requirements | 2026-01-01 |
| Cigna EviCore | MOL.AD.314.A: Date of Service and Authorization Period Effective Date | 2026-01-01 |
| Cigna EviCore | MOL.AD.364.A: Special Circumstances Influencing Coverage Determinations | 2026-01-01 |
| Cigna EviCore | MOL.AD.412.A: Laboratory Billing and Reimbursement | 2026-01-01 |
| Cigna EviCore | MOL.CU.109.A: Genetic Testing for Cancer Susceptibility and Hereditary Cancer Syndromes | 2026-01-01 |
| Cigna EviCore | MOL.CU.110.A: Genetic Testing for Carrier Status | 2026-01-01 |
| Cigna EviCore | MOL.CU.111.A: Genetic Testing for Non-Medical Purposes | 2026-01-01 |
| Cigna EviCore | MOL.CU.112.A: Genetic Testing for Prenatal Screening and Diagnostic Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.113.A: Genetic Testing for the Screening, Diagnosis, and Monitoring of Cancer | 2026-01-01 |
| Cigna EviCore | MOL.CU.114.A: Genetic Testing to Diagnose Non-Cancer Conditions | 2026-01-01 |